Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 2
2021 8
2022 8
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Enhancement of Tumor Cell Immunogenicity and Antitumor Properties Derived from Platinum-Conjugated Iron Nanoparticles.
Hernández ÁP, Iglesias-Anciones L, Vaquero-González JJ, Piñol R, Criado JJ, Rodriguez E, Juanes-Velasco P, García-Vaquero ML, Arias-Hidalgo C, Orfao A, Millán Á, Fuentes M. Hernández ÁP, et al. Among authors: juanes velasco p. Cancers (Basel). 2023 Jun 15;15(12):3204. doi: 10.3390/cancers15123204. Cancers (Basel). 2023. PMID: 37370813 Free PMC article.
Systematic Evaluation of Antigenic Stimulation in Chronic Lymphocytic Leukemia: Humoral Immunity as Biomarkers for Disease Evolution.
Landeira-Viñuela A, Alcoceba-Sanchez M, Navarro-Bailón A, Arias-Hidalgo C, Juanes-Velasco P, Sánchez-Santos JM, Lecrevisse Q, Pedreira CE, García-Vaquero ML, Hernández ÁP, Montalvillo E, Góngora R, De Las Rivas J, González-Díaz M, Orfao A, Fuentes M. Landeira-Viñuela A, et al. Among authors: juanes velasco p. Cancers (Basel). 2023 Jan 31;15(3):891. doi: 10.3390/cancers15030891. Cancers (Basel). 2023. PMID: 36765855 Free PMC article.
Exploring High-Throughput Immunoassays for Biomarker Validation in Rheumatic Diseases in the Context of the Human Proteome Project.
Fuentes M, Ruiz-Romero C, Misiego S, Juanes-Velasco P, Landeira-Viñuela A, Torres-Roda A, Lorenzo-Gil H, González-González M, Hernández ÁP, Lourido L, Sjöberg R, Pin E, de Las Rivas J, Sánchez-Santos JM, Nilsson P, Blanco FJ. Fuentes M, et al. Among authors: juanes velasco p. J Proteome Res. 2023 Apr 7;22(4):1105-1115. doi: 10.1021/acs.jproteome.2c00387. Epub 2022 Dec 7. J Proteome Res. 2023. PMID: 36475733
Translational research into frailty from bench to bedside: Salivary biomarkers for inflammaging.
Niebla-Cárdenas A, Bareke H, Juanes-Velasco P, Landeira-Viñuela A, Hernández ÁP, Montalvillo E, Góngora R, Arroyo-Anlló E, Silvia Puente-González A, Méndez-Sánchez R, Fuentes M. Niebla-Cárdenas A, et al. Among authors: juanes velasco p. Exp Gerontol. 2023 Jan;171:112040. doi: 10.1016/j.exger.2022.112040. Epub 2022 Nov 28. Exp Gerontol. 2023. PMID: 36455696 Free article. Review.
Unravelling soluble immune checkpoints in chronic lymphocytic leukemia: Physiological immunomodulators or immune dysfunction.
Landeira-Viñuela A, Arias-Hidalgo C, Juanes-Velasco P, Alcoceba M, Navarro-Bailón A, Pedreira CE, Lecrevisse Q, Díaz-Muñoz L, Sánchez-Santos JM, Hernández ÁP, García-Vaquero ML, Góngora R, De Las Rivas J, González M, Orfao A, Fuentes M. Landeira-Viñuela A, et al. Among authors: juanes velasco p. Front Immunol. 2022 Sep 28;13:965905. doi: 10.3389/fimmu.2022.965905. eCollection 2022. Front Immunol. 2022. PMID: 36248816 Free PMC article.
Systematic evaluation of plasma signaling cascades by functional proteomics approaches: SARS-CoV-2 infection as model.
Juanes-Velasco P, García-Vaquero ML, Landeira-Viñuela A, Lopez-Campos JL, Marín C, Lecrevisse Q, Arias-Hidalgo C, Montalvillo E, Góngora R, Hernández ÁP, Fuentes M. Juanes-Velasco P, et al. Proteomics Clin Appl. 2022 Nov;16(6):e2100100. doi: 10.1002/prca.202100100. Epub 2022 Oct 13. Proteomics Clin Appl. 2022. PMID: 36168869 Free PMC article.
Comprehensive and systematic characterization of multi-functionalized cisplatin nano-conjugate: from the chemistry and proteomic biocompatibility to the animal model.
Hernández ÁP, Micaelo A, Piñol R, García-Vaquero ML, Aramayona JJ, Criado JJ, Rodriguez E, Sánchez-Gallego JI, Landeira-Viñuela A, Juanes-Velasco P, Díez P, Góngora R, Jara-Acevedo R, Orfao A, Miana-Mena J, Muñoz MJ, Villanueva S, Millán Á, Fuentes M. Hernández ÁP, et al. Among authors: juanes velasco p. J Nanobiotechnology. 2022 Jul 20;20(1):341. doi: 10.1186/s12951-022-01546-y. J Nanobiotechnology. 2022. PMID: 35858906 Free PMC article.
Single-Cell Proteomics: The Critical Role of Nanotechnology.
Arias-Hidalgo C, Juanes-Velasco P, Landeira-Viñuela A, García-Vaquero ML, Montalvillo E, Góngora R, Hernández ÁP, Fuentes M. Arias-Hidalgo C, et al. Among authors: juanes velasco p. Int J Mol Sci. 2022 Jun 16;23(12):6707. doi: 10.3390/ijms23126707. Int J Mol Sci. 2022. PMID: 35743151 Free PMC article. Review.
SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS.
Juanes-Velasco P, Landeira-Viñuela A, García-Vaquero ML, Lecrevisse Q, Herrero R, Ferruelo A, Góngora R, Corrales F, Rivas JL, Lorente JA, Hernández ÁP, Fuentes M. Juanes-Velasco P, et al. Front Immunol. 2022 Jan 28;13:732197. doi: 10.3389/fimmu.2022.732197. eCollection 2022. Front Immunol. 2022. PMID: 35154090 Free PMC article.
22 results